(BION) BB Biotech - Performance -29.4% in 12m
Compare BION with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-65.00%
#88 in Group
Rel. Strength
23.86%
#6059 in Universe
Total Return 12m
-29.43%
#70 in Group
Total Return 5y
-41.70%
#53 in Group
P/E 13.2
55th Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -47.72%
(?) Percentile in Group
12m Total Return: BION (-29.4%) vs XBI (-12.3%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
10.1% | 18% | 166% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
14.3% | 31.2% | 47% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-2.93% | -8.78% | 30.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
9.55% | 9.34% | 30.4% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
0.78% | 17.8% | -2.14% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
21.4% | 25.3% | -4.13% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
34.3% | -15.5% | 3.48% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
20.4% | -0.39% | 7.63% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: BION vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for BION
Total Return (including Dividends) | BION | XBI | S&P 500 |
---|---|---|---|
1 Month | 4.78% | 11.81% | 13.81% |
3 Months | -23.70% | -13.61% | -6.30% |
12 Months | -29.43% | -12.29% | 10.65% |
5 Years | -41.70% | -24.89% | 107.77% |
Trend Score (consistency of price movement) | BION | XBI | S&P 500 |
1 Month | 85.5% | 72.9% | 83% |
3 Months | -91.0% | -83% | -75.3% |
12 Months | -76.9% | -51.6% | 50.1% |
5 Years | -86.5% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #109 | -6.28% | -7.94% |
3 Month | #111 | -11.7% | -18.6% |
12 Month | #70 | -19.5% | -36.2% |
5 Years | #55 | -22.4% | -71.9% |
FAQs
Does BION BB Biotech outperforms the market?
No,
over the last 12 months BION made -29.43%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.29%.
Over the last 3 months BION made -23.70%, while XBI made -13.61%.
Over the last 3 months BION made -23.70%, while XBI made -13.61%.
Performance Comparison BION vs Indeces and Sectors
BION vs. Indices BION is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -7.43% | -9.03% | -19.0% | -40.1% |
US NASDAQ 100 | QQQ | -7.62% | -12.6% | -19.2% | -41.1% |
US Dow Jones Industrial 30 | DIA | -7.84% | -5.21% | -18.7% | -37.1% |
German DAX 40 | DAX | -7.41% | -10.2% | -45.2% | -55.1% |
Shanghai Shenzhen CSI 300 | CSI 300 | -9.61% | -7.05% | -19.7% | -36.8% |
Hongkong Hang Seng | HSI | -10.6% | -15.2% | -27.3% | -43.1% |
India NIFTY 50 | INDA | -2.51% | -0.06% | -19.4% | -29.2% |
Brasil Bovespa | EWZ | -8.48% | -12.5% | -27.7% | -21.1% |
BION vs. Sectors BION is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -8.07% | -8.63% | -26.0% | -51.0% |
Consumer Discretionary | XLY | -7.81% | -9.45% | -18.0% | -43.7% |
Consumer Staples | XLP | -6.57% | -1.81% | -25.9% | -38.6% |
Energy | XLE | -7.25% | -1.98% | -12.4% | -20.0% |
Financial | XLF | -8.53% | -8.74% | -26.1% | -51.9% |
Health Care | XLV | -4.42% | 3.91% | -14.0% | -25.4% |
Industrial | XLI | -9.12% | -12.0% | -20.4% | -40.4% |
Materials | XLB | -7.23% | -8.78% | -14.1% | -24.2% |
Real Estate | XLRE | -6.11% | -6.76% | -19.7% | -44.9% |
Technology | XLK | -8.51% | -16.4% | -16.1% | -36.5% |
Utilities | XLU | -7.48% | -4.81% | -26.6% | -46.9% |
Aerospace & Defense | XAR | -9.41% | -16.4% | -30.5% | -56.8% |
Biotech | XBI | -0.84% | -7.03% | 1.19% | -17.1% |
Homebuilder | XHB | -7.90% | -6.70% | -5.76% | -21.9% |
Retail | XRT | -9.33% | -9.87% | -14.7% | -28.0% |